Masafumi Yasunaga
Overview
Explore the profile of Masafumi Yasunaga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Asanoma K, Yahata H, Kodama K, Okugawa K, Yasunaga M, Onoyama I, et al.
Asian J Endosc Surg
. 2025 Jan;
18(1):e70015.
PMID: 39757529
Introduction: This study examined factors that affected sentinel lymph node (SLN) identification of patients with endometrial cancer having a preoperative estimation of low recurrent risk. Methods: This study included 97...
2.
Tokui H, Yahata H, Okabe Y, Magarifuchi N, Maenohara S, Hachisuga K, et al.
Int Cancer Conf J
. 2024 Mar;
13(2):162-166.
PMID: 38524644
Adult granulosa cell tumors are rare, accounting for only 3-5% of all ovarian tumors. Adult granulosa cell tumors have late recurrences, for which complete resection is an effective option. We...
3.
Asanoma K, Yagi H, Onoyama I, Cui L, Hori E, Kawakami M, et al.
J Biol Chem
. 2024 Feb;
300(3):105695.
PMID: 38301894
BHLHE40 is a basic helix-loop-helix transcription factor that is involved in multiple cell activities including differentiation, cell cycle, and epithelial-to-mesenchymal transition. While there is growing evidence to support the functions...
4.
Hachisuga K, Kawakami M, Tomonobe H, Maenohara S, Kodama K, Yagi H, et al.
Int J Gynecol Pathol
. 2024 Jan;
43(6):573-585.
PMID: 38289146
The administration of immune checkpoint inhibitors (ICIs) is increasing in endometrial cancer, especially in the mismatch repair (MMR)-deficient group. To prevent unnecessary immune-related adverse events, ICIs need to be administered...
5.
Kodama K, Tateishi C, Oda T, Cui L, Kuramoto K, Yahata H, et al.
Cancer Sci
. 2023 Aug;
114(11):4216-4224.
PMID: 37648257
Indocyanine green (ICG) with near-infrared (NIR) fluorescence imaging is used for lymphatic mapping. However, binding of ICG to blood proteins like serum albumin can shorten its retention time in sentinel...
6.
Yasunaga M, Yahata H, Okugawa K, Hori E, Hachisuga K, Maenohara S, et al.
Am J Clin Oncol
. 2023 Jun;
46(9):387-391.
PMID: 37272748
Objective: The aim of this study was to evaluate the progression-free survival (PFS) and overall response rate (ORR) of patients with recurrent endometrial cancer (REC) or advanced endometrial cancer (AEC)...
7.
Kawahara R, Midorikawa R, Taniwaki S, Kojima S, Kanno H, Yoshitomi M, et al.
Kurume Med J
. 2023 Apr;
68(2):81-89.
PMID: 37005293
Background: Distal bile duct carcinoma continues to be one of the most difficult cancers to manage in terms of staging and radical resection. Pancreaticoduodenectomy (PD) with regional lymph node dissection...
8.
Okugawa K, Yahata H, Ohgami T, Yasunaga M, Asanoma K, Kobayashi H, et al.
J Gynecol Oncol
. 2023 Feb;
34(3):e41.
PMID: 36807744
Objective: To apply the International Federation of Gynecology and Obstetrics (FIGO) 2018 staging system to all patients who underwent trachelectomy in our previous study and to update the oncologic and...
9.
Yagi H, Onoyama I, Asanoma K, Kawakami M, Maenohara S, Kodama K, et al.
Cancer Gene Ther
. 2022 Oct;
30(2):313-323.
PMID: 36257976
Dysregulated G protein-coupled receptor signaling is involved in the formation and progression of human cancers. The heterotrimeric G protein Gα is highly expressed in various cancers and regulates diverse cancer-related...
10.
Asanoma K, Yahata H, Okugawa K, Ohgami T, Yasunaga M, Kodama K, et al.
J Obstet Gynaecol Res
. 2022 Sep;
48(12):3226-3232.
PMID: 36110050
Aim: Westernization of lifestyle has increased the numbers of patients with endometrial cancer and obesity. This study aimed to compare the clinical outcomes of robotic-assisted surgery according to whether patients...